Lenvatinib and Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous
Determining the interaction of Lenvatinib and Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
Generic Name: measles virus vaccine / mumps virus vaccine / rubella virus vaccine / varicella virus vaccine
Brand name: ProQuad
Synonyms: Measles, mumps, rubella, and varicella virus vaccine live (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib-Mebaral
- Lenvatinib-Mebendazole
- Lenvatinib-Mebolex
- Lenvatinib-Mebrofenin
- Lenvatinib-Mecamylamine
- Lenvatinib-Mecamylamine Hydrochloride Tablets
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvatinib Mesylate
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvima
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvima (14 MG Daily Dose)
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvima (18 MG Daily Dose)
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvima (20 MG Daily Dose)
- Measles, mumps, rubella, and varicella virus vaccine live Subcutaneous-Lenvima (24 MG Daily Dose)